Artivion, Inc. (AORT) company profile

Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues for patients suffering from aortic diseases. The company operates through two primary reportable segments: Medical Devices and Preservation Services. Its medical device offerings include aortic stent grafts, mechanical heart valves, surgical sealants, and related surgical tools. Through its preservation services, the company cryopreserves and supplies human cardiac and vascular donor tissues. Its offerings are primarily used by cardiac and vascular surgeons treating aortic aneurysms, dissections, and heart valve conditions.

The company maintains a global commercial presence, distributing products across North America, Latin America, the Asia-Pacific region, Europe, the Middle East, and Africa. Its operational footprint includes key subsidiaries based in Hechingen, Germany, and Austin, Texas, alongside approximately twenty regional corporate entities dedicated to international sales and marketing operations. The provided text does not state the location of the company's corporate headquarters.

Summary of the business section of Artivion's latest annual report, written by StockData.

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

“As of December 31, 2025 we had approximately 1,800 employees.”